The relators’ reverse FCA claim was based on Pfizer’s alleged breach of its obligations under a CIA it had entered into with the U.S. Department of Health and Human Services (“HHS”).

In fiscal year 2015, more than $1 Billion of the Government’s False Claims Act (FCA) recovery was derived from cases in which the Government declined ...